Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 10
Association of dopamine D1 receptor gene polymorphism with schizophrenia: a meta-analysis
Authors Pan Y, Yao J, Wang B
Received 8 March 2014
Accepted for publication 15 April 2014
Published 20 June 2014 Volume 2014:10 Pages 1133—1139
DOI https://doi.org/10.2147/NDT.S63776
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 5
Yuqing Pan, Jun Yao, Baojie Wang
Institute of Forensic Medicine, China Medical University, Shenyang, People’s Republic of China
Abstract: To date, the role of dopamine D1 receptor (DRD1) polymorphism in schizophrenia remains controversial. We carried out a meta-analysis to determine whether DRD1 polymorphism influences the risk of schizophrenia. We examined whether rs4532 and rs5326 genetic variants are related to the etiology of schizophrenia, using a meta-analysis. Relevant case-control studies were retrieved by database searching and selected according to established inclusion criteria. A total of ten studies were identified and included in our meta-analysis, nine for rs4532, with 1,941 cases and 2,480 controls, and four for rs5326, with 1,285 cases and 1,195 controls. No significant association was found between the rs4532 locus and schizophrenia. For the rs5326 locus, the guanine-adenine (GA) genotype was associated with schizophrenia as a risk factor (for GA vs guanine-guanine [GG], odds ratio [OR] =1.36, 95% confidence interval [CI]: 1.15–1.61, P<0.001). The GA genotype of rs5326 increased the risk of schizophrenia, but there was no association between rs4532 and schizophrenia. These data may provide references for case-control studies in schizophrenia in future.
Keywords: susceptibility, SNP, genetics, psychiatry
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.